News Feature Channel: Diabetes

Edible Bird's Nest-Infused Beverage: A New Weapon in the Fight Against Hypertension

Chinese Academy of Sciences — Mon, 18 Nov 2024 08:30:39 EST

A recent study highlights the health benefits of a cocoa-flavored, soy-based powder drink mix enriched with hydrolysates from edible bird's nests. This innovative functional beverage shows promise in managing hypertension and inflammation, along with improving glycemic control and prolonging satiety. The study focuses on the drink's angiotensin-converting enzyme (ACE) inhibition and red blood cell membrane stabilization effects, suggesting a fresh approach to dietary management of chronic health issues.

UTSW Epidemiologist to Receive AHA Distinguished Scientist Award

UT Southwestern Medical Center — Wed, 13 Nov 2024 14:05:05 EST

Jiang He, M.D., Ph.D., Professor and Chair Designate of Epidemiology in the Peter O'Donnell Jr. School of Public Health at UT Southwestern Medical Center, is a 2024 recipient of the American Heart Association's (AHA) highest commendation, the Distinguished Scientist award. The honor recognizes Dr. He's prolific research on reducing the risks of cardiometabolic diseases, including heart disease, stroke, obesity, Type 2 diabetes, hypertension, dyslipidemia, and chronic kidney disease.

Hackensack University Medical Center to Hold Annual Diabetes Awareness Month Event

Hackensack Meridian Health — Tue, 12 Nov 2024 12:45:40 EST

Researchers Suggest Stress Hormones Explain How Obesity Causes Diabetes

Rutgers University-New Brunswick — Tue, 12 Nov 2024 10:20:26 EST

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a Rutgers Health study.

New Study Links Liver-Brain Communication to Daily Eating Patterns

Perelman School of Medicine at the University of Pennsylvania — Thu, 07 Nov 2024 14:00:00 EST

People who work the nightshift or odd hours and eat at irregular times are more prone to weight gain and diabetes, likely due to eating patterns not timed with natural daylight and when people typically eat. But is it possible to stave off the ill effects of eating at these "unusual" times despite it not being biologically preferable?

UW-Madison researchers find persistent problems with AI-assisted genomic studies

University of Wisconsin-Madison — Mon, 04 Nov 2024 15:20:32 EST

University of Wisconsin-Madison researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical characteristics, including risk factors for diseases like diabetes.The faulty predictions are linked to researchers' use of AI to assist genome-wide association studies.

COVID-19 Sharply Boosts Risk for Blood-Fat Disorders

Albert Einstein College of Medicine — Fri, 01 Nov 2024 09:40:39 EST

A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase in risk for developing dyslipidemia, a condition involving abnormal lipid (fat) levels in the blood. Seniors and people with type 2 diabetes were even more strongly affected, experiencing an approximately two-fold increased risk for developing dyslipidemia, which is a major risk factor for cardiovascular diseases such as heart attack and stroke. The research was published today in the print edition of The Journal of Clinical Investigation.

Don't Let Diabetes Dim Your Vision

American Society of Retina Specialists — Fri, 01 Nov 2024 07:45:53 EST

During November's Diabetic Eye Disease Awareness Month, the American Society of Retina Specialists encourages people with diabetes, their friends, and loved ones to learn more about diabetic retinopathy and diabetic macular edema and prioritize their eye health to protect and preserve vision.

Sustained Remission of Diabetes and Other Obesity-Related Conditions Found a Decade After Weight Loss Surgery in Adolescence

Ann and Robert H. Lurie Children's Hospital of Chicago — Wed, 30 Oct 2024 17:00:00 EST

Ten years after undergoing bariatric surgery as teens, over half of study participants demonstrated not only sustained weight loss, but also resolution of obesity-related conditions, such as type 2 diabetes, high blood pressure and high cholesterol, according to the report published in the New England Journal of Medicine.

Most Patients Can Continue Diabetes, Weight Loss GLP-1 Drugs Before Surgery, Those at Highest Risk for GI Problems Should Follow Liquid Diet Before Procedure

American Society of Anesthesiologists (ASA) — Tue, 29 Oct 2024 18:25:35 EST

Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons. Patients at the highest risk for significant gastrointestinal (GI) side effects should follow a liquid diet for 24 hours before the procedure or other measures, depending on the specific circumstances.

Think You've Outgrown Your High School Years? When It Comes To Drinking, A New Study Suggests Maybe Not

Research Society on Alcoholism — Sun, 27 Oct 2024 10:00:00 EST

Adults aged 35 to 60 are drinking at unprecedented rates, with those who binge drank in high school reporting more past 30-day high-risk drinking in midlife. And this link may be especially strong for women, according to a study just published in Alcohol: Clinical and Experimental Research Health. These trends are particularly concerning as health conditions, and biological processes common with aging put adults in midlife at greater health risk from alcohol use.

Do Certain Diabetes Drugs Increase the Risk of Acute Kidney Injury in Patients Taking Anti-Cancer Therapies?

American Society of Nephrology (ASN) — Fri, 25 Oct 2024 19:30:00 EST

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA-associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA-associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that taking GLP-1RA is not associated with an increased risk of AKI in patients receiving anti-cancer therapies. The findings will be presented at ASN Kidney Week 2024 October 23- 27.

Researchers Integrate Multiple Protein Markers to Predict Health Outcomes in Individuals with Chronic Kidney Disease

American Society of Nephrology (ASN) — Fri, 25 Oct 2024 19:30:00 EST

Prior efforts to identify novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have typically evaluated proteins individually, which limits their prognostic power. The National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK's) CKD Biomarkers Consortium of investigators recently developed and tested novel dimensions of kidney health by combining a set of 17 urine and plasma biomarkers that had been individually associated with CKD progression. The research will be presented at ASN Kidney Week 2024 October 23- 27.

Heart and Kidney Outcomes After Canagliflozin Treatment in Older Adults

American Society of Nephrology (ASN) — Fri, 25 Oct 2024 19:30:00 EST

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients' age. A recent analysis of clinical trial data reveals that the SGLT2 inhibitor canagliflozin benefited patients across all age categories. The findings will be presented at ASN Kidney Week 2024 October 23 - 27.

High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health: Part 1

American Society of Nephrology (ASN) — Fri, 25 Oct 2024 13:30:00 EST

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23-27.

Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease

Case Western Reserve University — Thu, 24 Oct 2024 07:00:00 EST

Researchers at the Case Western Reserve School of Medicine have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

CHLA Endocrinologist to Co-Lead New Nationwide Study Investigating the Impacts of Type 1 Diabetes on Childhood Brain Development

Children's Hospital Los Angeles — Wed, 23 Oct 2024 11:45:59 EST

A new research study co-led by Jennifer Raymond, MD, MCR, Chief of the Center for Endocrinology, Diabetes and Metabolism at CHLA, is launching at 12 U.S. sites to explore how Type 1 diabetes affects the development of children's brains during key growth periods. The five-year study is funded by a $2.7 million National Institutes of Health (NIH) grant.

A New Therapy to Prevent or Delay Type 1 Diabetes Now Available at UNC Children's Hospital

University of North Carolina Health Care System — Wed, 23 Oct 2024 09:20:28 EST

Physician scientists at the UNC School of Medicine played a pivotal role in getting this therapy to the bedside, from assisting with clinical trials to the infusion of the first pediatric patient in North Carolina at UNC Children's.

AI Tool Helps Identify Heart Failure Risk in Diabetes Patients

UT Southwestern Medical Center — Tue, 22 Oct 2024 09:05:59 EST

Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart's structure and function that predisposes them to increased risk of heart failure. The findings, published in the European Journal of Heart Failure, offer a data-driven method to detect a high-risk diabetic cardiomyopathy phenotype, enabling early interventions that could help prevent heart failure in this vulnerable population.

People with Type 2 Diabetes Who Eat Low-Carb May Be Able to Discontinue Medication

Endocrine Society — Tue, 22 Oct 2024 09:00:00 EST

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.